Viracta Therapeutics Inc (NASDAQ:VIRX)
| 1.95 Delayed Data As of 3:59pm ET |  +0.07 / +3.72%Today’s Change | 1.21 Today|||52-Week Range 5.75 | +33.56% Year-to-Date |
Latest VIRX News | Press Releases
No recent news for Viracta Therapeutics Inc.
Today’s Trading
| Previous close | 1.88 |
| Today’s open | 1.83 |
| Day’s range | 1.83 - 1.95 |
| Volume | 641 |
| Average volume (3 months) | 111,436 |
| Market cap | $72.6M |
Data as of 3:59pm ET, 02/07/2023
Growth & Valuation
| Earnings growth (last year) | +32.91% |
| Earnings growth (this year) | +61.06% |
| Earnings growth (next 5 years) | -- |
| Revenue growth (last year) | -100.00% |
| P/E ratio | NM |
| Price/Sales | -- |
| Price/Book | 0.80 |
Competitors
| Today’s change | Today’s % change | |
|---|---|---|
| --Immunovia AB (publ) | 0.00 | 0.00% |
| OCUPOcuphire Pharma Inc | +0.07 | +2.01% |
| LIFEaTyr Pharma Inc | +0.01 | +0.41% |
| TNXPTonix Pharmaceutical... | -0.03 | -2.92% |
Data as of 4:00pm ET, 02/07/2023
Financials
| Next reporting date | March 15, 2023 |
| EPS forecast (this quarter) | -$0.36 |
| Annual revenue (last year) | $0.00 |
| Annual profit (last year) | -$114.8M |
| Net profit margin | -- |
Profile
Sector Health Technology |
Industry Biotechnology |
No executives to display |
Corporate headquarters Cardiff, California |
Forecasts
